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Recently we demonstrated that IGF-1 expression is increased in the diabetic kidney and that it may involve in 
renal hypertrophy and extracellular matrix protein (ECM) accumulation in mesangial cells as seen in diabetic 
glomerulopathy. The present study investigates the molecular mechanism(s) of IGF-1 and Akt/glycogen 
synthase kinase-3beta (GSK-3β) signaling pathway in the regulation of fibronectin and cyclin D1 expression and 
survival of renal mesangial cells. A proteomic approach is also employed to identify protein targets of IGF-1 
signaling via GSK-3β inhibition in mesangial cells. We show that IGF-1 (100 ng/ml) significantly increases the 
protein kinase Akt/PKB activity (1.5-2-fold, p<0.05) within 1-5 minutes, which is completely blocked by the 
presence of 100 nM Wortmannin (phosphatidyl-inositol 3-kinase inhibitor). Akt activation is coupled with Ser9 
phosphorylation and inactivation of its down-stream target GSK-3β. IGF-1 increases the cyclic AMP-responsive 
element (CRE) binding transcription factor CREB phosphorylation at Ser 133 and CRE-binding activity in 
mesangial cells, which parallels cyclin D1 and fibronectin expressions. Both proteins are known to have 
CRE-sequences in their promoter regions upstream of the transcription start site. Suppression of GSK-3β by 
SB216763 (100 nM) increases CREB phosphorylation, cyclin D1 and fibronectin levels. Two dimensional gel 
electrophoresis followed by MALDI-TOF mass spectrometric analysis of mesangial proteins reveals that IGF-1 
treatment or an inhibition of GSK-3β increases the expression of the phosphorylated Ser/Thr binding signal 
adapter protein 14-3-3ζ.  Immuno-precipitation of 14-3-3ζ followed by Western blotting validates the association 
of phosphorylated GSK-3β with 14-3-3ζ in renal mesangial cells. Stable expression of a constitutively active 
GSK-3β(Ser9Ala) induces cell death while overexpression of HA-tagged 14-3-3ζ increases cell viability as 
measured by MTT assays. These results indicate that the Akt/GSK-3β pathway and the adapter protein 14-3-3ζ 
may play an important role in IGF-1 signaling and survival of mesangial cells in diabetic nephropathy. 
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1.  INTRODUCTION 
Diabetic glomerular disease, like all forms of 
glomerular sclerosis, is characterized by deranged 
glomerular remodeling consisting of enhanced 
extracellular matrix (ECM) accumulation and altered 
cell growth leading to an enlargement of the 
mesangial region [1, 2]. Recent studies indicate that 
Insulin-like growth factor –1 (IGF-1) is accumulated in 
diabetic kidney and involves in the expansion of 
glomerular mesangium and the development of 
diabetic glomerular sclerosis. IGF–1 is a 
multifunctional growth factor produced in a variety of 
tissues including kidney [3, 4] and is considered to 
participate in the pathology of diabetic renal disease 
[5, 6]. Increased expression and accumulation of IGF-1 
peptide, mRNA and IGF-1 binding to its receptor are 
observed in diabetic glomerulopathy [7-9]. In patients 
with type 1 diabetes, elevated urinary IGF-1 is 
associated with hypertrophy and progression of 
kidney disease [10, 11]. The signaling pathways by 
which IGF-1 promotes cell growth, proliferation and 
hypertrophy of renal cells remain largely undefined.  
Insulin and IGF-1 signaling involves activation 
of phosphatidyl inositol 3 kinase (PI3K) and the 
downstream Akt/PKB, which in turn phosphorylates 
GSK-3α at Ser 21 and GSK-3β at Ser 9, and inhibits its 
kinase activity [12]. Both isoforms have a similar 
range of substrate specificities and are regulated in 
parallel in response to growth factor stimulation. 
However, disruption of GSK-3β gene in mice results 
in embryonic lethality, indicating that GSK-3α can‘t 
completely substitute for a loss of GSK-3β [13]. 
GSK-3β has been studied more extensively than the 
α-form, and we have employed this isoform in our 
recent studies [14]. In MCF-7S breast cancer cells, an 
inhibition of GSK-3β by IGF-1 or LiCl, a known 
inhibitor of GSK-3β, results nuclear accumulation of 
cyclin D1 and cell cycle progression [15]. Recently, we 
showed that IGF-1 increases mesangial cell 
hypertrophy and laminin β1 and γ1 expression in in 
vitro cell cultures and that the Akt/GSK-3β may 
participate in these processes [14]. There also exists 
signal cross-talks between Akt/GSK-3β and 
calcium-dependent protein phosphatase 2B (PP2B or 
calcineurin) pathways. Other investigators observed 
that IGF-I treatment of mesangial cells increases the 
synthesis of calmodulin and calcineurin activity [16]. Int. J. Biol. Sci. 2007, 3  28
Cyclosporin A, an inhibitor of calcineurin, blocks both 
IGF-1-induced NFATc1 nuclear translocation and 
up-regulation of fibronectin and collagen IV in 
mesangial cells [16].  
Hyperglycemia-induced ECM gene expression 
involves activation of several transcription factors 
including the cyclic AMP responsive element (CRE) 
binding protein, CREB, and GC binding protein, Sp1. 
These transcription factors are regulated by high 
glucose in mesangial cells [17-19]. Most ECM genes 
bear CREB and Sp1 binding consensus sequences in 
their promoters [20-23]. The activation of genes 
bearing CRE is thought to occur by the 
phosphorylation of CREB at Ser 133 and binding to 
CRE consensus sequences in the promoter region of 
genes [24, 25]. We have previously shown that high 
glucose-induced fibronectin protein synthesis is 
associated with parallel changes in the level of CREB 
phosphorylation and CRE binding activity in 
mesangial cells [26-28]. IGF-1 is a potent activator of 
CREB in a variety of cells types [29]; however, IGF-1’s 
effects on CREB activity in mesangial cells are not 
known yet. Here, we demonstrate that IGF-1 increases 
fibronectin and cyclin D1 expression in mesangial 
cells and is associated with enhanced phosphorylation 
and DNA-binding activity of CREB. A proteomic 
analysis reveals that IGF-1 increases the expression of 
the signal adapter protein, 14-3-3ζ, in mesangial cells 
and it is associated with GSK-3β and its down-stream 
target beta-catenin. 14-3-3 proteins are ubiquitous 
eukaryotic acidic polypeptides of ~32 kDa that binds 
to serine or threonine residues of phosphorylated 
proteins and play a regulatory role in intracellular 
signal transduction, cell-cycle progression, 
differentiation and apoptosis. Therefore, 
Akt/GSK-3β and the scaffold protein 14-3-3ζ may 
play a role in IGF-1 signaling to regulate cell cycle 
progression, ECM expression and survival of renal 
mesangial cells.  
2.  MATERIALS AND METHODS 
Materials 
Insulin-like growth factor-1, PI3-K inhibitor, 
Wortmannin, and antibodies for cyclin D1, and 
α-actin were purchased from Upstate Biotechnology, 
Lake Placid, NY. Antibodies for phosphorylated and 
non-phosphorylated GSK-3β, and 14-3-3ζ antibodies 
and its competitive peptides were obtained from 
Santa Cruz, CA. Anti-cyclin D1 and phosphorylated 
Akt substrate motif specific antibodies were 
purchased form Cell Signaling Technology, Danvers, 
MA. MTT [3-(4,5-dimethylthiazol-2-yl)-2-,5- 
diphenyltratrazolium bromide], Hoechst Dye 33342, 
anti-fibronectin and fluorescence-labeled secondary 
antibodies were purchased from Molecular Probes, 
Eugene, OR. SH-5 (Akt inhibitor) was from Alexis 
(San Diego, CA) while GSK-3β inhibitor, SB216763, 
was obtained from Calbiochem, San Diego. The 
enhanced chemiluminescence (ECL) system was 
obtained from Amersham (Arlington Heights, IL). 
DMEM and F-12 nutrient mixture (Ham's) were from 
GIBCO (Grand Island, NY). The gel-shift assay kit was 
purchased from PROMEGA, Wisconsin. 
Cell Culture 
An immortalized rat mesangial cell line was 
cultured in medium containing  DMEM and Ham's 
F-12 (3:1 ratio) supplemented with 2.25% fetal calf 
serum (FCS) and 0.5 mg/ml gentamicin at 37°C in a 
humidified chamber with a 5% CO2-95% air mixture 
[14]. Monolayers at 60-70% confluence were 
serum-starved overnight and varying amounts of 
IGF-1 (100 ng/ml) was added for different time 
intervals. For this time course, IGF-1 with 24 h 
treatment was added first, then on the second day 
IGF-1 was added at 6, 2 or 0 h to the respective 
cultures before harvesting the cells. Thus, all cells 
including the control maintain a similar condition and 
length of serum-starvation during the entire 
experimental procedure [14]. MES cells were 
harvested and proteins extracted in RIPA buffer. The 
protein concentrations were  determined using a 
Coomassie-based reagent from Pierce with BSA as the 
standard. When the inhibitors are included in the 
culture, they were added 30 minute before adding 
IGF-1, and were present throughout the period of 
incubation. 
SDS-PAGE, Western Blotting and 
Immunoprecipitation 
Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis and Western blot analysis of proteins 
were performed as described previously [14]. 
Immunoprecipitation of mesangial proteins 
associated with 14-3-3ζ was performed using Protein 
G/A-agarose-conjugated 14-3-3ζ antibodies and the 
bound proteins were specifically dissociated with a 
10x higher concentration of a competitive peptide 
derived from 14-3-3ζ  (Santa Cruz). Five hundred 
microgram of protein extracts were incubated with 50 
μl of pre-absorbed Protein G/A-agarose-anti-14-3-3ζ 
antibodies overnight. The bound proteins were eluted 
with ten-fold excess of the 14-3-3ζ specific peptide. 
The resulting proteins were separated on SDS-PAGE 
and subjected to Western blotting. 
 Akt/PKB activity assay 
The kinase activity of Akt/PKB in mesangial cell 
extracts was determined using an antibody-based 
immunoprecipitation assay kit from Upstate 
Biotechnology, Lake Placid, NY, as described before 
[30]. 
Fluorescence Immunohistochemistry 
Mesangial cells were grown either in 
four-chambered tissue culture glass slides (NUNC, 
Naperville, IL) and exposed to IGF-1 (100 ng/ml) for 
different time periods (0-24 h). Cells were fixed with 
freshly prepared paraformaldehyde (4%) for 2 h in ice 
or 4 oC overnight, washed 10 min each with PBS (3 
times) and blocked with 5% horse serum in PBS for 1 h 
at room temperature. Following a 30 minutes wash 
with PBS, cells were incubated with primary 
antibodies for 2 h at 37 oC in a humidified chamber. 
Primary antibody dilution for chicken anti-fibronectin 
antibodies was 1:200 (v/v) and mouse anti-α-tubulin 
was 1:500 (v/v). After washing with PBS, cells were 
further incubated with corresponding secondary 
antibodies conjugated with Alexa Fluor 488 or RITC at 
1:500 dilution for 1 h at 37 oC in a darkened 
humidified chamber. After washing with PBS again, 
mesangial cells were mounted with an aqueous 
mounting medium with anti-fade agent and sealed Int. J. Biol. Sci. 2007, 3  29
with nail polish. The cell-associated fluorescence was 
observed in an Olympus BX51 Fluorescence 
microscope fitted with a DP70 CCD camera and 
images were analyzed by image analysis software of 
the microscope and combined by Microsoft Adobe 
Photosoft.  
Gel-shift assay 
The gel-shift, or electrophoretic mobility-shift, 
assay provides  a simple and rapid method for 
detecting DNA-binding activity  of proteins. We 
investigated the CREB activity of mesangial nuclear 
proteins by using a commercially available gel-shift 
assay kit from Promega as described before [21]. An 
18-mer oligonucleotide containing CRE consensus 
sequence 5'-TGACGTCA-3' was 5'-labeled with T4 
polynucleotide  kinase and (γ-32P)ATP, and the 
radiolabeled CRE were separated on a G-25 Sephadex 
Spin column (Boehringer Mannheim). After 
incubation at 30°C for 10 min with 32P-CRE, nuclear 
extracts ( 7.5 µg protein) were subjected to 6% 
nondenaturing polyacrylamide  gels prepared with 
TBE gel formulation (supplied by the manufacturer). 
The gels were run at 100 V for 1 h until the 
Bromophenol blue dye front is three quarters down 
the gel, using 0.5x TBE running buffer. The gel was 
covered with Saran Wrap and exposed to X-ray films. 
For competitive and noncompetitive assays, 10xcold 
CRE or GC sequence (a sequence specific for Sp1 
transcription factor), were respectively used.  
  Two-Dimensional Gel Electrophoresis and 
MALTI-TOF Mass Spectrometry 
The proteomic analysis to identify proteins in 
mesangial cells were performed at the Michigan 
Proteome Consortium, Core facility at the University 
of Michigan, Ann Arbor [31]. Protein  samples  were 
prepared in 7M Urea, 2M Thiourea, 0.002% 
Bromophenol Blue, 2 mM tributyl phosphine and 
0.5% IPG Buffer. Due to the presence of some 
interfering materials in the cellular extracts, proteins 
were precipitated with TCA and re-suspended in the 
above buffer again. First dimensional isoelectric 
focusing was performed in a BioRad Protean IEF cell 
(pH 4-7 and 18 cm strips) and the second dimension in 
a Protean Plus Dodeca Cell [Bio Rad]. Gels in 
triplicates from each condition, e.g., control, IGF-1 
treated (100 ng/ml) or SB216763 (100 nM GSK3β 
inhibitor) for 24 h, were stained with Colloidal 
Commassie blue to detect protein spots.  Bio-rad 
PDQuest 2D software was used to analysis and 
quantitate the spot intensities. Automated spot 
picking of proteins of interest was performed by the 
robotic system Ettan Spot Picker (Amersham 
Pharmacia Biotech), and the in-gel tryptic digestion 
was achieved using a MassPrep Robotic Workstation 
(MicroMass, UK). Tryptic digests were analyzed using 
matrix-assisted laser desorption/ionization (MALDI) 
time of flight (MALDI-TOF) ms or ms/ms mass 
spectrometry using α-cyano 4-hydroxy cinnamic acid 
as the carrier matrix (Applied Biosystems). Peptide 
masses were submitted to SwissProt and NCBInr 
databases for peptide mass fingerprinting (PMF) and 
protein identification using MS-Fit for ms data search 
[http://prospector.ucsf.edu/] or MASCOT MS/MS 
Ion Search for ms/ms data analysis 
[http://www.matrixscience.com]. Peptides were 
assumed to be carbamidomethylated at cysteine 
residues, and allowed up to 1 missed tryptic cleavage 
and 50-ppm mass tolerance. 
Real-time quantitative PCR 
Fibronectin mRNA expression was analyzed by 
real-time quantitative PCR using the ABI Prism 
7900HT sequence detection system and SYBR Green 
PCR Master Mix from Applied Biosystems (Foster 
City, CA). Primers were designed using Primer 
Express v 2.0 [Applied Biosystems] and synthesized 
by Invitrogen (Carlsbad, CA).  
Primer sequences of genes for the real-time 
Q-PCR are: 
1. Fibronectin (Fn) [Accession no. X93167]  
forward (region 209-229) 5’-CTGGGGTCA 
CGTACCTCTTCA-3’  
reverse (region 389-369) 
5’-AGTCGGTAGCCTGCTATACGG-3’;  
2. S18: [NM_138946] 
forward (region 24-44) 
5’-GCACAGTGTTTGTAGAGCCTG-3’ 
reverse (region 170-149) 
5’-GCCCTGGAACTTATTGATCGGG-3’.  
The real time PCR reaction mixture contained 1X 
SYBR Green PCR Master Mix, 400 nM forward and 
reverse primers, and 10 ng total cDNA in a final 
volume of 25 μl. The PCR cycling was programmed as 
95 oC for 15s and 60 oC for 20s for 40 cycles followed 
by the construction of a melting curve through 
increasing the temperature from 60 oC to 95 oC at a 
ramp rate of 2% for 20 min. The real time PCR samples 
were evaluated using a single predominant peak as a 
quality control. Ct values were used to calculate the 
relative expression level of fibronectin mRNAs that 
were normalized to endogenous cellular 18S. The 
numbers of real time PCR cycles at which fluorescent 
signals reached a detection threshold was set within 
the exponential phase of the PCR. 
Generation of stably transfected GSK-3β(S9A) and 
HA-tagged 14-3-3ζ expressing mesangial cells 
The constitutively active Ser 9 to Ala mutated 
GSK-3β(S9A) and haemagglutinin-(HA)-tagged 
14-3-3ζ in pcDNA3.1 plasmids were used to generate 
stably overexpressing mesangial cells and a 
corresponding empty pcDNA3.1 control cell line. The 
expression vector for GSK-3β(S9A) was kindly 
provided by Dr. Woodgett from the University of 
Toronto Health Sciences, Toronto, and the HA-tagged 
14-3-3ζ plasmid was provided by Drs. Kosie 
Bialkowska and Joan Fox of Cleveland Clinic 
Foundation, Cleveland, OH. Rat mesangial cells were 
plated in a six-well plate and grown overnight to 
~50% confluence and serum-starved. Cells were 
transfected with 1.0 μg DNA per well in 100 μl 
serum-free DMEM containing 20 μl of Lipofectamine 
Plus [Invitrogen] in duplicate wells. Three hours later, 
the media was replaced with serum containing 
DMEM:F-12 (4:1 ratio) medium containing G418 (400 
μg/ml). When the cells reach 90-95% confluence they 
were trysinized and transferred to 10 cm plates and 
maintained in media containing the same amount of 
G418 (400 μg/ml).  
Cell Viability Assay 
MTT assay for cell proliferation and viability was Int. J. Biol. Sci. 2007, 3  30
performed in 24 well plates and with 0.5 mg/ml MTT 
in each well as recently described in our laboratory [14, 
31]. Mesangial cells (1x104 cells) were grown to 70% 
confluence and serum-starved overnight. IGF-1 100 
ng/ml was added for 4-24 h and MTT was added for 3 
h. The media was removed and cells were kept in 100 
μl of DMSO for 10 minutes. The resulting color was 
diluted with 500 μl of distilled H2O and detected at 
570 nm using a Gemini Microplate reader. 
Statistical Analysis 
Results are expressed as means +/-SE of 
indicated number of experiments. Student’s t test was 
used to compare differences between cultures. A 
value of P<0.05 was consider statistically significant.  
Figure 1. Effect of IGF-1 on AKT/GSK-3β activity and cyclin D1 expression in mesangial cells. (A) Mesangial cells 
were grown to 60-70% confluence, serum-starved overnight and treated with IGF-1 (100 ng/ml) for 1-5 min with or without 
100 nM Wortmannin. Cell extracts (500 μg protein) were immunoprecipitated with anti-Akt antibodies and kinase activity 
was determined by using an Akt/PKB assay kit from Upstate Biotechnology. The basal Akt activity was ~4.8 pmol 
32Pi 
incorporated into Akt peptides/0.5 mg protein/10 min (n=5). (B) Mesangial cells were serum-starved overnight and 
incubated with IGF-1 (100 ng/ml) for different time periods: 0, 1, 3, 5, and 10 min, respectively, and 30 μg proteins were 
subjected to Western Blotting with anti-phospho-GSK-3β antibodies (n=3). The membrane was stripped and reprobed with 
anti-GSK-3α/β antibodies. (C) Mesangial cells were treated with IGF-1 (100 ng/ml) for 0, 2, 6 and 12 h and were subjected 
to Western blotting for cyclin D1 and reprobed for α-tubulin (a representative of n=3). 
 
 
3.  RESULTS 
IGF-1 regulates the Akt/GSK-3β pathway and cyclin 
D1 expression in mesangial cells 
IGF-1 is a cell growth factor and the signaling 
pathway involves the activation of PI3-K and Akt 
kinase. Here, we examine the effect of IGF-1 on Akt 
activity and Ser 9 phosphorylation of its target GSK-3β 
in mesangial cells. The Akt activity in mesangial cells 
increases within 1 minute of IGF-1 (100 ng/ml) 
addition and reaches a maximal stimulation of ~2.4- 
fold versus the control at time 0 (p, <0.05, n=5). 
Afterwards it falls down but maintains a higher 
activity than the control (Figure 1A). The Akt activity 
is completely suppressed by the presence of 100 nM 
Wortmannin, an inhibitor of up-stream PI3-kinase. 
IGF-1 activation of Akt is associated with an increase 
in the phosphorylation of GSK-3β at Ser9 as detected Int. J. Biol. Sci. 2007, 3  31
by the anti-GSK-3β(S9P) antibodies on Western blots 
(Figure 1B). The GSK-3β phosphorylation is increased 
within 1 min of IGF-1 addition, and is highest at 5 min. 
However, total GSK-3β is not affected by IGF-1. 
Furthermore, IGF-1 treatment of mesangial cells leads 
to an increase in the expression of the cell cycle 
regulator cyclin D1 (Figure 1C). The expression is 
enhanced gradually from 0-12 h upon IGF-1 treatment. 
Under these experimental conditions, IGF-1 does not 
alter α-tubulin expression. 
IGF-1 increases fibronectin mRNA and protein 
expression in mesangial cells 
We further examined if IGF-1 regulates the 
expression of fibronectin mRNA and protein in 
mesangial cells by quantitative RT-PCR and 
immunohistology. IGF-1 increases fibronectin mRNA 
levels significantly at 2 h (1.76+/-0.3 folds, p<0.05, 
n=4), then decreases at 6 and 24 h (Figure 2A). On the 
other hand, fibronectin protein levels are increased at 
2 (as well as at 6h) and 24 h as revealed by the 
immunofluorescence microscopy (Figure 2B). In 
addition, IGF-1 also increases fibronectin protein 
levels in mouse and human mesangial cells (data not 
shown).  α-tubulin expression appears to be slightly 
elevated at 24 h of IGF-1 treatment as well.  
Figure 2. Quantitative RT-PCR and fluorescence immunohistochemical staining of fibronectin. (A) Mesangial cells 
were incubated with IGF-1 (100 ng/ml) for different time intervals (0-24 h). Total RNA was isolated using Trizol reagent 
and performed the real-time 
quantitative PCR as described in 
Methods. The expression level of 
fibronectin were normalized to S-18 
and the relative fibronectin mRNA 
expression is presented (n=4). The 
symbol (*) represents statistically 
significant change as compared to 
controls at 0 time. [B] Mesangial cells 
were grown in four-chambered glass 
slides (NUNC, Naperville, IL) and 
exposed to IGF-1 (100 ng/ml) for 
different time periods (0, 2, and 24 h). 
Cells were fixed with freshly 
prepared paraformaldehyde, 
permeabilized using 1% Nonidet 
P-40 detergent, and stained for 
immunofluorescence with 
appropriate primary and 
fluorescent-labeled secondary 
antibodies as described under 
Methods. The pictures are 
representatives of 3 different 
experiments for each protein. 
 
IGF-1 increases phosphorylation 
of CREB at Ser133 and its 
DNA-binding activity in 
mesangial cells 
Most ECM genes, including 
fibronectin, and cyclin D1 contain 
in their promoters cis-acting 
elements for cAMP-responsive 
element binding transcription 
factor CREB [21-23]. Therefore, 
we investigated whether IGF-1 
has an influence on CREB phosphorylation and the 
CRE DNA-binding activity in mesangial cells. As 
shown in Figure 3A, IGF-1 increases the 
phosphorylation of CREB at Ser133 in a 
time-dependent manner (0-12 h) as detected by an 
antibody directed against the phosphorylated CREB 
at Ser 133 [upper band]. The antibody also detects 
another band below, the phospho-ATF, which has a 
similar motif. However, the total CREB content is not 
changed. In addition, IGF-1 also increases the 
CRE-binding activity of mesangial nuclear extracts 
(Figure 3B). The binding is specifically inhibited by a 
10-fold excess of cold CRE, a competitive sequence; 
but not by the GC consensus sequence of Sp1 
transcription factor binding site (non-competitive 
sequence).  
Inhibition of GSK-3β increases CREB 
phosphorylation and cyclin D1 expression 
We examined here whether an inhibition of Akt 
or GSK-3β has an effect on IGF-1-mediated CREB 
phosphorylation and cyclin D1 expression in 
mesangial cells. As shown in Figure 4A, IGF-1 
increases CREB phosphorylation in 2 h (lanes 1 and 2) 
and an inhibition of GSK-3β  by 100 nM SB216763 
further enhances the level of CREB phosphorylation 
(lanes 2 and 4). Similar results are also seen for cyclin 
D1 expression in Figure 4B (lanes 2 and 4). An Int. J. Biol. Sci. 2007, 3  32
inhibition of Akt by SH-5 (2 μM) reduces both CREB 
phosphorylation and cyclin D1 expression (lane 3 in 
Figures 4A and 4B). Fibronectin expression is also 
increased by IGF-1 or upon the incubation 
of mesangial cells with GSK-3β inhibitor, 
SB216763 (100 nM) alone for 24 h (Figure 4C). In 
general, IGF-1 or GSK-3β inhibition increases the cell 
and nuclear size as compared with controls. 
Figure 3. CREB phosphorylation and 
CRE-binding in mesangial cells. (A) CREB 
phosphorylation and total CREB contents were 
detected in nuclear extracts of mesangial cells on 
Western blots as described in Methods. A 
representative of n=3 is shown. (B) EMSA: 
Nuclear extracts (6 μg protein) were incubated 
with 
32P-CRE (~100,000 cpm) for 10 min and 
applied to 6% non-denaturing minigels at 100 V 
for 45 min until dye reaches the bottom of the gel. 
Lane 1. Time 0 (control); lane 2. 2 h; lane 3. 4 h; 
lane 4. 6 h; lane 5. 12 h; land 6. 12 h + 10-fold 
excess of cold CRE (competitive inhibition) and 
lane 7. 12 h + 10 fold excess a Sp1 DNA 
fragment (non-competitive control). A 
representative of n=3 is shown.  
 
Two-dimensional gel electrophoresis and 
MALFI-TOF mass spectrometry of 
mesangial proteins 
To further understand the IGF-1 
signaling and protein expression involving 
GSK-3β, we compared proteome profiles of 
mesangial cells after treatment with IGF-1 
(100 ng/ml) or SB216763 (100 nM, GSK-3β 
inhibitor) for 24 h against the control. Cell 
lysates were resolved by 2-D gel 
electrophoresis and stained with Colloidal 
Coomassie blue and digitized. The images from the 
control (without treatment) and IGF-1 or SB216763 
treated cells were compared by 2D gel software 
PDQuest for changes in the protein expression. Three 
hundred and ninety six distinctive protein spots were 
commonly detected in all 9 gels (triplicates for each 
treatment condition) and they were subjected to 
statistical analysis using 95% confidential intervals. 
The differential expression of protein spots beyond 
0.5-2-fold was considered down or up regulated by 
IGF-1 and GSK-3β treatment. Fifty two spots were 
found commonly changed by both treatments. 
Twenty five spots containing some of the commonly 
regulated spots (as shown in Figure 5A) were 
subjected to automatic gel cutting, in-gel tryptic 
digestion and MALDI-TOF ms or ms/ms analysis for 
protein identification. The 3D view of proteins around 
the spot #17 is shown in Figure 5B to demonstrate that 
the proteins chosen for analysis were not overlapped 
with other spots. Similar analysis was also performed 
for the other spots selected for identification. Peptide 
mass fingerprinting (PMF) was performed using both 
NCBInr and SwissProt protein sequence database 
search engines. 
A typical ms/ms spectra for the proteins, e.g., 
that of the spot #17 which is identified as the 
phospho-protein docking protein 14-3-3ζ, is shown in 
Figure 6A. A list of proteins identified by the 
2D-gel/mass spectrometric analysis is shown in Table 
1. As seen from this list, the fact that IGF-1 treatment 
or an inhibition of GSK-3β promotes protein synthesis 
elongation factor γ1 (EF-γ1 )  g o e s  p a r a l l e l  t o  c e l l  
growth activity of IGF-1. At the same time, both IGF-1 
and GSK-3β a l s o  d o w n  r e g u l a t e  e n d o p l a s m i c  
reticulum-associated proteins, such as calreticulin, 
calumenin and protein disulfide isomerase A3, 
suggesting ER stress of these cells. Among the 
proteins identified, the expression of the 
phospho-Ser/Thr binding adapter protein 14-3-3ζ 
(shown in bold letters in Table 1) was further 
investigated as this protein is considered to be 
involved in cell cycle control and survival involving 
various protein kinase/phosphatase signaling 
pathways. The 2D/mass spectrometric and PMF data 
is further validated as IGF-1 increases 14-3-3ζ 
expression on Western blots (Figure 6B, upper panel). 
On the other hand, IGF-1 receptor α level is 
marginally decreased probably due to the 
ligand-receptor complex internalization and recycling 
(Figure 6B, middle panel). α-Tubulin expression is not 
changed under these conditions. 
IGF-1 increases Akt target phosphorylation and 
phospho-GSK-3β association with 14-3-3ζ 
We investigated if down-stream phosphoprotein 
targets of Akt including GSK-3β are associated with 
the phospho-protein binding adapter 14-3-3ζ in 
mesangial cells  and whether IGF-1 has an influence 
on their interaction. Μesangial cells were treated with 
IGF-1 (100 ng/ml) for 2 h and total cellular extracts 
were subjected to Western blotting with primary 
antibodies targeted against a phosphorylated Akt 
peptide motif (R-X-R-X-X-S*/T*); therefore, it 
recognizes most phosphoproteins that are targeted by 
Akt. As shown in Figure 7A (left panel), Akt targeted Int. J. Biol. Sci. 2007, 3  33
phosphoproteins of different molecular sizes were 
increased by IGF-1. To further examine which of these 
Akt targets will bind to 14-3-3ζ, the 14-3-3ζ 
immunoprecipitates were subjected to Western 
blotting with the same anti-phospho-Akt motif 
antibodies. The results reveal that a major band at 
48-kDa and another weak band at 40-kDa are bound 
to 14-3-3ζ (Figure 7A, right). GSK-3β is a 48-kDa 
protein and is a target of Akt. Therefore, the 14-3-3ζ 
immune complexes were further blotted with 
antibodies against phosphorylated GSK-3β(S9P) and 
β-catenin (a target of GSK-3β). As shown in Figure 7B, 
the presence of GSK-3β(S9P) and β-catenin are 
detected in the 14-3-3ζ complex. In addition, the 
binding of 14-3-3ζ itself is increased while total 
GSK-3α/β level is not changed. However, the presence 
o f  c y c l i n  D 1  a n d  C R E B  i n  t h e  1 4 - 3 - 3 ζ 
immunoprecipitates was not detected under the 
experimental conditions.  
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Figure 4. Effect of Akt and 
GSK-3β inhibition on CREB 
phosphorylation and cyclin 
D1 and fibronectin expression. 
Mesangial cells were grown to 
70% confluence and 
serum-starved overnight. 
Inhibitors for Akt/PKB (2 μM, 
SH-5) and GSK-β (100 nM, 
SB216763) were pre-treated for 
30 min before adding IGF-1 
(100 ng/ml) for 2 h. Cell 
extracts (30 μg protein) were 
subjected to Western blotting 
for (A) phosphorylated and total 
CREB and (B) for cyclin D1. 
Lane 1. Control; lane 2. IGF-1, 
2h; lane 3. IGF-1, 2h+SH-5 (2 
μM); and lane 4. IGF-1, 
2h+SB216763 (100 nM). 
Representative blots from three 
different experiments are shown. 
(C). Effect of IGF-1 (100 ng/ml) 
or SB216763 (100 nM) on 
fibronectin expression upon 24 
h exposure was determined by 
immunofluorescence 
microscopy. Nuclear staining 
was performed with Hoechst 
Dye 33342 and fibronectin with 
Alexis 488 (n=3).  
 
Effect of stable expression of 
constitutively active 
GSK-3β[S9A] and 
HA-14-3-3ζ on IGF-1-mediated mesangial cell 
survival 
In order to elucidate further a role for GSK-3β 
and 14-3-3ζ in IGF-1 signaling and mesangial cell 
survival, a phosphorylation insensitive Ser 9 to Ala 
mutant GSK-3β(S9A), which is a constitutively active 
kinase, and HA-tagged 14-3-3ζ were transfected in rat 
mesangial cells. After 3 passages with G418, the cells 
were examined for GSK-3β and HA-14-3-3ζ 
expression on Western blots. There was ~1.5-fold 
increases in GSK-3β levels in GSK-3β(S9A) stables 
cells and ~2-fold increased level of 14-3-3ζ in 
HA-14-3-3ζ expressing mesangial cells. No 
morphological differences among these three cell line 
is observed under the phase contrast microscope 
(Figure 8A). Control pcDNA3.1, GSK-3β(S9A) or 
HA-tagged 14-3-3ζ stable mesangial cells were grown 
to ~70-80% confluence in 24 well plates. IGF-1 at 100 
ng/ml was added to each well for 0, 4, 6 or 24 h and 
cell viability was assayed by MTT. As shown in Figure 
8B, IGF-1 increases mesangial cell viability at 6 and 24 
h significantly (p<0.05 versus control at time 0 in 
pcDNA3.1 cells, left panel). However, cell viability 
and IGF-1 effects are reduced in GSK-3β(S9A) 
overexpressors significantly (p<0.05 between 
pcDNA3.1 and GSK-3β(S9A) at 0 time, and p<0.001 
between GSK-3β(S9A) at 0 and 24 h, middle panel). 
On the other hand, MTT absorbance is increased 
significantly (p<0.05 versus pcDNA3.1 control at 0 
time) in HA-14-3-3ζ expressing cells and IGF-1 
treatment does not have an additional effect on 
mesangial cell viability (right panel).  
4.  DISCUSSION 
IGF-1 is one of the growth factors that are 
implicated in renal growth, hypertrophy and the 
progression of diabetic glomerulopathy because of its 
persistent accumulation in the diabetic kidney. 
Recently, we demonstrated that higher expression of 
IGF-1 in the diabetic kidney is associated with 
increases in ECM protein levels and cell cycle control 
factors such as cyclin D1 and p21Cip1 [14]. In addition, 
the phosphorylation of the transcription factor CREB 
at Ser 133 is also increased in the diabetic kidney 
without affecting the total CREB content (unpublished 
data). In this study, using a proteomic approach, we 
demonstrate that IGF-1 regulates Akt/GSK-3β 
signaling pathway, fibronectin expression and 
survival of mesangial cells and that the 
phospho-protein docking adaptor 14-3-3ζ interacts 
with GSK-3β to regulate cell survival. It is also 
noteworthy that IGF-1 induces the expression of 
fibronectin mRNA at 2 h maximally and then returns 
to the level of the control while the elevation of 
protein content continues up to 24 h. These results 
suggest that mRNA and protein levels do not always 
correlate and that post-transcriptional mechanism(s) 
of gene expression regulation may be equally 
important in determining the overall accumulation of 
ECMs in the diabetic glomerulopathy. In this regard, 
we have recently shown that TGF-β1 increases 
fibronectin and laminin N-linked glycosylation in 
renal mesangial cells, which retards the rate of ECM 
degradation [32]. It is still unknown whether IGF-1 is 
involved in ECM glycosylation and degradation; Int. J. Biol. Sci. 2007, 3  35
however, an inactivation of matrix metalloproteinase 
(MMP-2) activity by IGF-1 is observed in mesangial 
cells isolated from non-obesed diabetic mice, which 
correlates with a decrease in the degradation of 
collagen type IV [33]. Recently, in a microarray study, 
we observed low level of ECM mRNA expression in 
mouse mesangial cells whereas the protein levels are 
consistently increased in mesangial cells and in the 
diabetic kidney [34]. Furthermore, we found that 
treatment of a mouse mesangial cell line in culture 
with IGF-1 increases mRNA stability for fibronectin at 
24 h when compared with non-treated control cells 
(data not shown). Hence, a small change in the 
transcriptional rates and/or mRNA stability may 
exert a profound effect at the level of cell function in 
chronic diseases such as diabetes and its vascular 
complications. 
Figure 5. Two-dimensional 
gel electrophoresis of 
mesangial proteins. 
Mesangial cells were cultured 
for 24 h with or without 100 
ng/ml IGF-1 or GSK-3β 
inhibitor, SB 216763 (100 nM) 
in triplicates. Cellular proteins 
were subjected to 2D gel 
electrophoresis and stained 
with Colloidal Coomassie blue. 
A representative 2-D gel 
image of the Control 
(triplicates were run for each 
condition) and twenty-five 
spots were subjected to 
MALDI-TOF ms and/or 
ms/ms analysis is shown in 
Figure A. Three-dimensional 
view of the spots around #17 is 
depicted in (B) as a 
representative to ensure that 




IGF-1 signaling leads 
to activation of the Akt 
activity in mesangial cells 
and phosphorylation of its 
down-stream substrate 
GSK-3β at Ser 9 [14]. This 
IGF-1 signaling pathway 
parallels an increase in the 
expression of the G0/G1 
cell cycle regulation factor 
cyclin D1, which is further 
stimulated by the inhibition 
of GSK-3β and completely 
blocked by Akt inhibitors 
(Figure 4B). Many ECM 
genes including fibronectin 
bear several cis-elements in 
their promoters such as 
cyclic AMP regulatory element (CRE), which is 
recognized by the CREB family of transcription factors 
[21-23]. We have previously shown that high glucose, 
glucosamine and TGF-β1 increases CREB 
phosphorylation and CRE-binding activity in 
mesangial cells and that these effects are mediated in 
part by protein kinases A and C, and they are 
involved in fibronectin and laminin expression [20, 
24]. The transcriptional activation of the cyclin D1 
gene expression is also mediated by cis-elements 
containing CREB sites [35]. Our observation that IGF-1 
is a stimulator of CREB phosphorylation at Ser 133 
and an activator of CRE consensus DNA-binding 
activity goes parallel to fibronectin and cyclin D1 
expression. An inhibition of GSK-3β by SB216763 
stimulates both CREB phosphorylation and cyclin D1 
expression suggesting a role for the Akt/GSK-3β 
pathway and transcription factor CREB in cell cycle 
regulation and ECM gene expression. GSK-3β does 
not target CREB at S133 but can be phosphorylated at 
Ser 129, a motif created by phosphorylated S133 [36]. 
Thus, the increase in the phosphorylation of CREB at 
Ser133 by IGF-1 or upon suppression of GSK-3β 
activity, observed in this study, appears to be an 
indirect effect either due to the inhibition of protein 
phosphatase(s) or activation of protein kinase(s) that 
target CREB at Ser 133. Further studies will be needed 
to answer these questions. Int. J. Biol. Sci. 2007, 3  36
 
Figure 6. MALDI TOF Mass spectrometry. 
(A) Peptide mass fingerprint spectra of Spot 
#17 and identification of protein 14-3-3ζ 
generated by Applied Biosystems (ABI) 
Proteomics Analyzer (MALDI-TOF/TOF) is 
shown here. Four peptides (*) were subjected 
to automatic ms/ms analysis, and protein 
identification was performed by both 
automatic and manual searches using Mascot 
MS/MS Ion Search or MS-Tag search tools. 
Both NCBI and SwissProt were used to search 
the protein database. (B) Proteomic data on 
IGF-1-induced 14-3-3ζ expression in 
mesangial cells is validated on Western blots. 
MES cells were treated with 100 ng/ml IGF-1 
for different time intervals (0, 2, 4, and 6h, 
respectively), and subjected to Western blots 
for 14-3-3ζ,  IGF-1 receptor α  and α-tubulin. 
IGF-1 stimulates 14-3-3ζ expression while 
IGF-1Rα  expression is decreased marginally 
probably due to ligand-receptor 
internalization and remodeling. α-tubulin is 










Figure 7. IGF-1 activation of Akt substrate phosphorylation and interaction of phospho-GSK-3β with 14-3-3ζ. 
Mesangial cells were grown to 70-80% confluence and serum-starved overnight. IGF-1 (100 ng/ml) was added for 2 h and 
cells were harvested as described in Methods. Total extracts were subjected to SDS-PAGE and Western blotting with 
phospho-Akt motif antibodies (Figure 7A, left panel). 14-3-3ζ immunoprecipitates were probed with the phospho-Akt motif 
antibodies (Figure 7A, right panel). In addition, the 14-3-3 ζ immunoprecipitates were subjected to Western blotting for 
14-3-3 ζ, GSK-3α/β, phosphorylated GSK-3β(S9P) and β-catenin (Figure 7B). The blots are representatives of three 
repeats.  
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Much interest has arisen to develop inhibitors of GSK-3β for several therapeutic uses, including the 
treatment of neurodegenerative diseases, type 2 diabetes, bipolar disorders, and chronic inflammatory disease. 
However, a direct inhibition of GSK-3β expression or blocking its activity might be expected to cause clinically 
deleterious effects inducing uncontrolled cell proliferation and tumor growth. Therefore, a comparative 
proteome analysis and the identification of IGF-1 target components of the Akt/GSK-3β pathway will help us to 
understand the IGF-1 signaling mechanism and glomerular mesangial cell function. Towards this goal, we 
began to undertake a 2D-gel/MALDI-TOF mass spectrometry-based proteomic approach of identifying 
abundant protein expression in mesangial cells after treatment of the cells with IGF-1 or with an inhibitor of 
GSK-3β, SB216763. Twenty-five of the expressed proteins were initially identified by mass spectrometry and 
peptide mass fingerprinting as shown in Table 1. One of the proteins identified by this technique is the 
phospho-Ser/Thr-binding signal adapter protein 14-3-3ζ (spot #17 in 2D-gel), whose expression is increased by 
IGF-1 and is found to be associated with GSK-3β by co-immunoprecipitation (Figures 5 and 6). We draw 
attention to this particular protein because 14-3-3 proteins are known to involve in the interaction with 
intracellular phospho-proteins and they are implicated in IGF-1 signaling [37], signal integration [38], cell cycle 
regulation and survival [39, 40]. Insulin and IGF-1 receptors are known to interact with similar cytoplasmic 
proteins and they share a common signal-transduction pathway. However, functionally they affect different 
cellular processes. For example, IGF-1 is more effective than insulin in promoting cell mitogenesis whereas 
insulin regulates cellular metabolic activities. 14-3-3 proteins selectively bind to IGF-1 receptor, but not to 
insulin receptor, and may contribute to the differences in IGF-1 and insulin receptor signal transduction and 
their down-stream cellular function [37]. 
Figure 8. Effect of stable expression of constitutively active GSK-3β(S9A) or 14-3-3ζ on mesangial cell viability. 
Mesangial cells stably overexpressing pcDNA3.1 (control), Ser9 to Ala mutated GSK-3β(S9A) or HA-tagged 14-3-3ζ were 
treated with 100 ng/ml IGF-1 for 0, 4, 6, and 24 h. Cell viability was determined by MTT as described in Methods. The 
symbol (*) represents statistically significant change compared with corresponding controls at 0 time for each cell line. The 
symbol (#) represents significant change when compared with the pcDNA3.1 control. The experiments were performed in 
triplicates and were repeated twice. 
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The association of GSK-3β with 14-3-3ζ has been 
demonstrated for the regulation of tau 
phosphorylation in neuronal cells [41]. Our findings 
that 14-3-3ζ is associated with GSK-3β and its 
down-stream signaling target β-catenin may provide a 
molecular and biochemical mechanism for GSK-3β 
regulation of β-catenin nuclear translocation and cell 
cycle progression in mesangial cells [14]. Recently, 
GSK-3β and 14-3-3 proteins have been shown to 
induce myocardial apoptosis, hypertrophy and 
fibrosis in streptozotocin-induced diabetic mice [42]. 
In addition to the identification of 14-3-3ζ  in the 
present study, the proteomic analysis also reveals that 
IGF-1 down-regulates several calcium-binding 
endoplasmic reticular proteins including calreticulin 
and calumenin (Table 1) indicating cell stress and 
calcium release from the ER storage. The regulation of 
ER calcium-binding proteins may lead to activation of 
calcium signaling and gene expression [43]. In fact, 
calcium/calmodulin dependent protein kinases and 
calcineurin play an important role in mesangial cell 
growth and ECM expression [12], and may influence 
14-3-3ζ interaction with phospho-protein targets to 
alter signaling pathways. Our findings that stable 
expression of 14-3-3ζ increases mesangial cell viability 
while expression of the non-phosphorylated active 
form of GSK-3β(S9A) reduces cell survival indicates 
that GSK-3β and 14-3-3ζ contribute to IGF-1 signaling 
and mesangial cell survival (Figure 8). GSK-3β is a 
negative regulator of IGF-1 signaling and cell survival; 
therefore, stable overexpression of this constitutively 
active kinase leads to blockade of IGF-1 effects on 
mesangial cell survival. On the other hand, 14-3-3ζ 
expression increases cell viability suggesting that it 
may trap or counteract the action of proapoptotic 
factors such as BAD and Bax [40]. Further attempts are 
being made to identify the Akt and GSK-3β−targeted 
phosphoproteins that interact with 14-3-3ζ using 
mesangial cells that express the HA-tagged 14-3-3ζ 
stably, pull-down protein capture methods and 
2D-gel/MALDI-TOF mass spectrometry. 
In summary, we have demonstrated that IGF-1 
stimulates Akt/GSK-3β pathway leading to CREB 
phsophorylation and CRE-binding activity in 
glomerular mesangial cells. IGF-1 increases 
fibronectin mRNA and protein levels in mesangial 
cells; however, mRNA and protein expression 
patterns do not go parallel. A proteomic analysis of 
IGF-1 signaling via the GSK-3β pathway identifies the 
scaffolding protein 14-3-3ζ to be up-regulated and 
associated with phosphorylated GSK-3β in mesangial 
cells. Stable expression of a phosphorylation 
insensitive and constitutively active form of 
GSK-3β(S9A) or HA-tagged 14-3-3ζ in mesangial cells 
alters IGF-1-mediated cell survival. The results imply 
that Akt/GSK-3β and 14-3-3ζ may mediate IGF-1 
signaling and contribute to cell growth, matrix gene 
expression and survival of renal mesangial cells in 
diabetic nephropathy leading to the development of 
glomerular sclerosis and end-stage renal disease.  
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